Drug costs within the US will rise by 13% attributable to Trump’s tariffs – forecast

Drug costs within the US will rise by 13% attributable to Trump's tariffs – forecast

Elevating tariffs on drug imports to the US by 25% will result in a $51 billion improve in drug prices per yr. Pharmaceutical imports will improve by 13%.